Skip to main content

Table 1 STHLM3 model for prostate cancer screening

From: Clinical proteomics for prostate cancer: understanding prostate cancer pathology and protein biomarkers for improved disease management

STHLM3 model [39]
Blood proteins PSA, fPSA, intact PSA, hK2, MSMB, MC1
Genetic polymorphisms 232 SNPs
Clinical variables Age, family history, previous prostate biopsy, prostate exam